Oscar Health reaffirms FY 2026 guidance at Raymond James conference

Oscar Health, Inc.

Participating in the 2026 Raymond James Institutional Investors Conference on March 2, 2026.
Reaffirming full-year 2026 guidance previously announced on Feb 10, 2026 in Q4/FY2025 earnings release.
No new financial metrics or changes to prior guidance disclosed in this filing.

item 7.01

Oscar Health, Inc. filing history →

Source: SEC EDGAR

accession 0001568651-26-000014

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.